Intelligent Bio Solutions (INBS) fell 17% after announcing a 1-for-10 reverse stock split to regain Nasdaq listing compliance. The stock will trade on a split-adjusted basis starting December 16, reducing outstanding shares to about 959,533. The move consolidates every 10 shares into one, with fractional shares settled in cash.